You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL2

Showing 1 - 25 of 677
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

Recruiting
  • Lung Cancer Stage III
  • Lung Cancer Stage IV
    • Brest, France
      Chu Brest
    Aug 16, 2023

    Myopia, Progressive Trial in Tianjin (Single vision lens, +2D PDL, +3D PDL)

    Active, not recruiting
    • Myopia, Progressive
    • Single vision lens
    • +3 more
    • Tianjin, China
      Tianjin Eye Hospital
    May 9, 2022

    NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Phase I - Mirdametinib - Level 1
    • +4 more
    • (no location specified)
    Jul 7, 2023

    NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • San Antonio, Texas
    • +2 more
    Aug 15, 2022

    SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

    Not yet recruiting
    • Urinary Bladder Neoplasm
      • (no location specified)
      Jun 17, 2022

      Locally Advanced or Metastatic Solid Tumors, NSCLC Trial in Australia (HLX301)

      Recruiting
      • Locally Advanced or Metastatic Solid Tumors
      • Non-small Cell Lung Cancer
      • Blacktown, New South Wales, Australia
      • +4 more
      May 25, 2022

      Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +3 more
      • Anti-PD-L1 Monoclonal Antibody IMC-001
      • Punch Biopsy
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

      Terminated
      Has Results
      • Metastatic Castration-resistant Prostate Cancer
      • Avelumab
      • 2nd generation ADT (abiraterone or enzalutamide)
      • New Orleans, Louisiana
        Tulane University School of Medicine
      Apr 6, 2022

      Melanoma, Non Small Cell Lung Cancer, Renal Cancer Trial in Clermont-Ferrand (Blood sample)

      Recruiting
      • Melanoma
      • +2 more
      • Blood sample
      • Clermont-Ferrand, France
        CHU de Clermont-Ferrand
      Jun 16, 2022

      Solid Tumor Trial in Richmond (Stereotactic radiotherapy, Biological: humanized anti-PD-1 mAb, Biological: humanized anti-PD-L1

      Completed
      Has Results
      • Solid Tumor
      • Stereotactic radiotherapy
      • +2 more
      • Richmond, Virginia
        Virginia Commonwealth University/Massey Cancer Center
      Dec 20, 2021

      Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

      Withdrawn
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +4 more
      • Bintrafusp Alfa
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 2, 2022

      Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,

      Active, not recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • Washington, District of Columbia
      • +5 more
      Dec 1, 2022

      Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

      Completed
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +2 more
      • Bintrafusp Alfa
      • Radiation Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 3, 2022

      T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in London (Avelumab)

      Completed
      • T-Cell Lymphoma Relapsed
      • T-Cell Lymphoma Refractory
      • London, United Kingdom
        University College London Hospital
      Oct 1, 2021

      Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

      Recruiting
      • Myelofibrosis Transformation in Essential Thrombocythemia
      • +2 more
      • Elotuzumab
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 17, 2021

      Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

      Terminated
      Has Results
      • Resectable Lung Non-Small Cell Carcinoma
      • +10 more
      • Bintrafusp Alfa
      • Therapeutic Conventional Surgery
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 27, 2022

      Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

      Recruiting
      • Metastatic Solid Tumors
      • +7 more
      • Scottsdale, Arizona
      • +12 more
      Jan 26, 2023

      Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),

      Active, not recruiting
      • Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
      • Bapotulimab (BAY1905254)
      • Bapotulimab (BAY1905254) + Pembrolizumab
      • Tucson, Arizona
      • +7 more
      Jan 12, 2023

      Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)

      Completed
      • Metastatic Renal Cell Carcinoma
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale Tumori
      Apr 23, 2021

      Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)

      Recruiting
      • Melanoma (Skin)
      • Non-Small-Cell Lung Carcinoma
      • GAd-PEV
      • MVA-PEV
      • Charleroi, Belgium
      • +6 more
      Feb 23, 2022

      Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II, Estrogen Receptor Positive and

      Completed
      • Microsatellite Stable Colorectal Carcinoma
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Mar 30, 2021

      Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

      Terminated
      • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
      • +9 more
      • Bintrafusp Alfa
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 4, 2022

      Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

      Recruiting
      • Anatomic Stage II Breast Cancer AJCC v8
      • +13 more
      • Bintrafusp Alfa
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 13, 2021

      Advanced Solid Tumor, NSCLC Trial in Taiwan, United States (NM21-1480)

      Recruiting
      • Advanced Solid Tumor
      • Non-small Cell Lung Cancer
      • NM21-1480
      • Pittsburgh, Pennsylvania
      • +3 more
      May 18, 2021